Logo.png
GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
December 05, 2023 09:05 ET | GRI Bio, Inc.
Clinical development plan potentially leveraging 505(b)(2) regulatory pathway Currently available treatments for IPF are limited to only two approved drugs that come with significant...
Global Clinical Trial Patient Recruitment Services Market
Global Clinical Trial Patient Recruitment Services Market Expected to Reach $1.56 Billion by 2030, Driven by Growing Pharma Sector
October 18, 2023 09:58 ET | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Area, By Age...
Global Healthcare BPO Market
Global Healthcare BPO Market Forecast Report 2023-2030: Driving Forces - Rising Demands for Pharmacovigilance Propel Market
September 07, 2023 06:38 ET | Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Healthcare BPO Market by Payer Service, Pharmaceutical Service, Provider Service - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
22157.jpg
Global SYK Inhibitors Market & Clinical Trials Outlook Report 2023-2028: Potential $300 Million Opportunity, 1 Marketed Drug, Current & Forecast Sales, Competitive Landscape
May 24, 2023 06:08 ET | Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Global SYK Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. This report contains a...
LOGO.jpg
QSAM Biosciences Expands its Study of CycloSam® in the Treatment of Bone Cancer; Opens Patient Enrollment at Key Chicago Center, Insight Hospital and Medical Center
May 23, 2023 08:00 ET | QSAM Biosciences Inc.
Austin, TX, May 23, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®), for...
22157.jpg
Outlook on the SYK Inhibitors Global Market to 2028 - Players Include Calithera Biosciences, CrystalGenomics, CSPC Ouyi Pharmaceutical, Genosco and Hanmi Pharmaceutical
February 24, 2023 05:18 ET | Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Global SYK Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. This report contains a...
22157.jpg
Patient Recruitment Services and Patient Retention Services Global Market Report 2022: Increasing Clinical Development Activity in Emerging Economies Drives Growth
December 08, 2022 08:43 ET | Research and Markets
Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Patient Recruitment Services and Patient Retention Services Market by Patient Recruitment Step, Trial Phase Therapeutic Area and Key Geographies,...
22157.jpg
$277+ Billion Worldwide Healthcare BPO Industry to 2031: Rapid Increase of Clinical Process Outsourcing is Significantly Driving Growth
October 21, 2022 04:28 ET | Research and Markets
Dublin, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The "Healthcare BPO Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers...
Phathom_Pharm_Logo_RGB.jpg
Phathom Pharmaceuticals to Present Latest Data on Vonoprazan at American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting
October 18, 2022 08:00 ET | Phathom Pharmaceuticals
FLORHAM PARK, N.J., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Global Clinical Trials Market
World Clinical Trials Market Report 2022: A Decline of 6% in 2020 Due to COVID-19 but a Market Valued at $78.3 Billion by 2030
June 28, 2022 04:28 ET | Research and Markets
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by Indication (Pain...